Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity

Clinical Immunology

Volumn 127, Issue 3, 2008, Pages 385-393

  Wong, Chun Kwok ^a   Lit, Lydia Choi Wan ^a   Tam, Lai Shan ^a   Li, Edmund Kwok Ming ^a   Wong, Purple Tsz Yan ^a   Lam, Christopher Wai Kei ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

IL 12; IL 17; IL 23; SLE; SLEDAI; Th17

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPERNATANT; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ADULT; AUTOIMMUNITY; CHEMOKINE CXCL10; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-23; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 45249097325     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.01.019     Document Type: Article

References (45)

1. Heinlen L.D., McClain M.T., Merrill J., Akbarali Y.W., Edgerton C.C., Harley J.B., and James J.A. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum. 56 (2007) 2344-2351
2. Mohan C., Adams S., Stanik V., and Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177 (1993) 1367-1381
3. Viallard J.F., Pellegrin J.L., Ranchin V., Schaeverbeke T., Dehais J., Longy-Boursier M., Ragnaud J.M., Leng B., and Moreau J.F. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 115 (1999) 189-195
4. Tokano Y., Morimoto S., Kaneko H., Amano H., Nozawa K., Takasaki Y., and Hashimoto H. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1-and Th2-derived cytokines. Clin. Exp. Immunol. 116 (1999) 169-173
5. Del Prete G. The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int. Rev. Immunol. 16 (1998) 427-455
6. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., and Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202 (2004) 96-105
7. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev., Immunol. 3 (2003) 133-146
8. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., and Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162 (1999) 4511-4520
9. Lankford C.S., and Frucht D.M. A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol. 73 (2003) 49-56
10. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 (2003) 1910-1914
11. Chen Z., Tato C.M., Muul L., Laurence A., and O'Shea J.J. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 56 (2007) 2936-2946
12. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 20 (2004) 467-476
13. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., and Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
14. Chen Y., Langrish C.L., McKenzie B., Joyce-Shaikh B., Stumhofer J.S., McClanahan T., Blumenschein W., Churakovsa T., Low J., Presta L., Hunter C.A., Kastelein R.A., and Cua D.J. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116 (2006) 1317-1326
15. Dinarello C.A. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103 (1999) 11-24
16. Hoshino T., Wiltrout R.H., and Young H.A. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J. Immunol. 162 (1999) 5070-5077
17. Yoshimoto T., Mizutani H., Tsutsui H., Noben-Trauth N., Yamanaka K., Tanaka M., Izumi S., Okamura H., Paul W.E., and Nakanishi K K. IL-18 induction of IgE: dependence on CD4 + T cells, IL-4 and STAT6. Nat. Immunol. 1 (2000) 132-137
18. Fehniger T.A., Shah M.H., and Turner M.J. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162 (1999) 4511-4520
19. Wong C.K., Li E.K., Ho C.Y., and Lam C.W.K. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology 39 (2000) 1078-1081
20. Wong C.K., Ho C.Y., Li E.K., Tam L.S., and Lam C.W. Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 130 (2002) 345-351
21. Wong C.K., Ho C.Y., Li E.K., and Lam C.W. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9 (2000) 589-593
22. Lit L.C., Wong C.K., Tam L.S., Li E.K., and Lam C.W. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 65 (2006) 209-215
23. Fantuzzi G., Reed D.A., and Dinarello C.A. IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J. Clin. Invest. 104 (1999) 761-767
24. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., and Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271-1277
25. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. the Committee on Prognosis studies in SLE, Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 35 (1992) 630-640
26. Hofstetter H.H., Grau C., Buttmann M., Forsthuber T.G., Gaupp S., Toyka K.V., and Gold R. The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells. Cytokine 40 (2007) 35-43
27. Wong C.K., Ho C.Y., Ko F.W., Chan C.H., Ho A.S., Hui D.S., and Lam C.W. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin. Exp. Immunol. 125 (2001) 177-183
28. Gocke A.R., Cravens P.D., Ben L.H., Hussain R.Z., Northrop S.C., Racke M.K., and Lovett-Racke A.E. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 178 (2007) 1341-1348
29. Lit L.C.W., Wong C.K., Li E.K., Tam L.S., Lam C.W.K., and Lo Y.M.D. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 34 (2007) 89-96
30. Kitching A.R., Turner A.L., Wilson G.R., Semple T., Odobasic D., Timoshanko J.R., O'Sullivan K.M., Tipping P.G., Takeda K., Akira S., and Holdsworth S.R. IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment. J. Am. Soc. Nephrol. 16 (2005) 2023-2033
31. Afzali B., Lombardi G., Lechler R.I., and Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148 (2007) 32-46
32. Kurasawa K., Hirose K., Sano H., Endo H., Shinkai H., Nawata Y., Takabayashi K., and Iwamoto I. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 43 (2000) 2455-2463
33. Huang X., Hua J., Shen N., and Chen S. Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients. Mod. Rheumatol. 17 (2007) 220-223
34. Tsai C.Y., Wu T.H., Yu C.L., Tsai Y.Y., and Chou C.T. Decreased IL-12 production by polymorphonuclear leukocytes in patients with active systemic lupus erythematosus. Immunol. Invest. 31 (2002) 177-189
35. Lauwerys B.R., Van Snick J., and Houssiau F.A. Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity. Lupus 11 (2002) 384-387
36. Hoeve M.A., Savage N.D., de Boer T., Langenberg D.M., de Waal Malefyt R., Ottenhoff T.H., and Verreck F.A. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur. J. Immunol 36 (2006) 661-670
37. Furuzawa-Carballeda J., Vargas-Rojas M.I., and Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6 (2007) 169-175
38. Bettelli E., Oukka M., and Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8 (2007) 345-350
39. Nakae S., Iwakura Y., Suto H., and Galli S.J. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81 (2007) 1258-1268
40. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., and de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8 (2007) 950-957
41. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., and Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8 (2007) 942-949
42. Kang B.Y., and Kim T.S. Targeting cytokines of the interleukin-12 family in autoimmunity. Curr. Med. Chem. 13 (2006) 1149-1156
43. Chang S.H., and Dong C. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res. 17 (2007) 435-440
44. Rohn T.A., Jennings G.T., Hernandez M., Grest P., Beck M., Zou Y., Kopf M., and Bachmann M.F. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol. 36 (2006) 2857-2867
45. Kikly K., Liu L., Na S., and Sedgwick J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18 (2006) 670-675